{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T22:42:15Z","timestamp":1778625735199,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","ijaaonline.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.ijantimicag.2015.10.010","type":"journal-article","created":{"date-parts":[[2015,11,4]],"date-time":"2015-11-04T12:02:12Z","timestamp":1446638532000},"page":"S29-S32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"S1","title":["Biomarkers in infection and sepsis: Can they really indicate final outcome?"],"prefix":"10.1016","volume":"46","author":[{"given":"Nikolaos","family":"Tziolos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasia","family":"Kotanidou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stylianos E.","family":"Orfanos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2015.10.010_bib0170","first-page":"1","article-title":"Inpatient care for septicemia or sepsis: a challenge for patients and hospitals","volume":"62","author":"Hall","year":"2011","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.ijantimicag.2015.10.010_bib0175","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00540-012-1502-7","article-title":"Clinical application of sepsis biomarkers","volume":"27","author":"Sankar","year":"2013","journal-title":"J Anesth"},{"key":"10.1016\/j.ijantimicag.2015.10.010_bib0180","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/00003246-200107000-00002","article-title":"Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care","volume":"29","author":"Angus","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2015.10.010_bib0185","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/MCC.0b013e3282c9ac2a","article-title":"Biomarkers to improve diagnostic and prognostic accuracy in systemic infections","volume":"13","author":"Schuetz","year":"2007","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.ijantimicag.2015.10.010_bib0190","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/SHK.0b013e3182a66bd6","article-title":"Role of biomarkers in sepsis care","volume":"40","author":"Samraj","year":"2013","journal-title":"Shock"},{"key":"10.1016\/j.ijantimicag.2015.10.010_bib0195","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.vph.2015.05.001","article-title":"Biological actions of pentraxins","volume":"73","author":"Vilahur","year":"2015","journal-title":"Vasc Pharmacol"},{"key":"10.1016\/j.ijantimicag.2015.10.010_bib0200","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ccc.2010.12.010","article-title":"Biomarkers in the critically ill patient: C-reactive protein","volume":"27","author":"Vincent","year":"2011","journal-title":"Crit Care Clin"},{"key":"10.1016\/j.ijantimicag.2015.10.010_bib0205","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3109\/10408363.2013.764490","article-title":"Biomarkers of sepsis","volume":"50","author":"Faix","year":"2013","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.ijantimicag.2015.10.010_bib0210","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.cyto.2014.06.010","article-title":"Elevated biomarkers of endothelial dysfunction\/activation at ICU admission are associated with sepsis development","volume":"69","author":"Vassiliou","year":"2014","journal-title":"Cytokine"},{"key":"10.1016\/j.ijantimicag.2015.10.010_bib0215","first-page":"97","article-title":"The correlation between procalcitonin, C-reactive protein and severity scores in patients with sepsis and their value in assessment of prognosis","volume":"27","author":"Wang","year":"2015","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"10.1016\/j.ijantimicag.2015.10.010_bib0220","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1097\/01.CCM.0000063440.19188.ED","article-title":"Comparison of procalcitonin and C-reactive protein as markers of sepsis","volume":"31","author":"Luzzani","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2015.10.010_bib0225","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1067\/msy.2003.70","article-title":"Inflammatory cytokines, C reactive protein, and procalcitonin as early predictors of necrosis infection in acute necrotizing pancreatitis","volume":"133","author":"Riche","year":"2003","journal-title":"Surgery"},{"key":"10.1016\/j.ijantimicag.2015.10.010_bib0230","doi-asserted-by":"crossref","DOI":"10.1007\/s12013-014-0446-y","article-title":"Therapeutic value of blood purification and prognostic utilities of early serum procalcitonin, C reactive protein, and brain natriuretic peptide levels in severely burned patients with sepsis","author":"Zu","year":"2015","journal-title":"Cell Biochem Biophys"},{"key":"10.1016\/j.ijantimicag.2015.10.010_bib0235","first-page":"451","article-title":"Procalcitonin in bacterial infections\u2014hype, hope, more or less?","volume":"135","author":"Christ-Crain","year":"2005","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.ijantimicag.2015.10.010_bib0240","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s10156-005-0388-9","article-title":"Multicenter prospective study of procalcitonin as an indicator of sepsis","volume":"11","author":"Aikawa","year":"2005","journal-title":"J Infect Chemother"},{"issue":"Suppl 1","key":"10.1016\/j.ijantimicag.2015.10.010_bib0245","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.ijantimicag.2007.06.032","article-title":"Circulating biomarkers as surrogates for bloodstream infections","volume":"30","author":"Muller","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2015.10.010_bib0250","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/bjs.4172","article-title":"Early measurement of procalcitonin does not predict severity in patients with acute pancreatitis","volume":"90","author":"Frasquet","year":"2003","journal-title":"Br J Surg"},{"key":"10.1016\/j.ijantimicag.2015.10.010_bib0255","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1007\/s00134-002-1398-z","article-title":"Procalcitonin: a marker to clearly differentiate systemic inflammatory response syndrome and sepsis in the critically ill patient?","volume":"28","author":"Giamarellos-Bourboulis","year":"2002","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ijantimicag.2015.10.010_bib0260","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1741-7015-10-2","article-title":"suPAR as a prognostic biomarker in sepsis","volume":"10","author":"Donadello","year":"2012","journal-title":"BMC Med"},{"key":"10.1016\/j.ijantimicag.2015.10.010_bib0265","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1093\/clinchem\/43.10.1868","article-title":"ELISA determination of soluble urokinase receptor in blood from healthy donors and cancer patients","volume":"43","author":"Stephens","year":"1997","journal-title":"Clin Chem"},{"key":"10.1016\/j.ijantimicag.2015.10.010_bib0270","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1469-0691.2004.00850.x","article-title":"The plasma level of soluble urokinase receptor is elevated in patients with Streptococcus pneumoniae bacteraemia and predicts mortality","volume":"10","author":"Wittenhagen","year":"2004","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2015.10.010_bib0275","doi-asserted-by":"crossref","first-page":"R149","DOI":"10.1186\/cc11463","article-title":"Risk assessment in sepsis: a new prognostication rule by APACHE II score and serum soluble urokinase plasminogen activator receptor","volume":"16","author":"Giamarellos-Bourboulis","year":"2012","journal-title":"Crit Care"},{"key":"10.1016\/j.ijantimicag.2015.10.010_bib0280","doi-asserted-by":"crossref","first-page":"R63","DOI":"10.1186\/cc10037","article-title":"Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients","volume":"15","author":"Koch","year":"2011","journal-title":"Crit Care"},{"key":"10.1016\/j.ijantimicag.2015.10.010_bib0285","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jinf.2011.07.016","article-title":"Soluble urokinase plasminogen activator receptor (suPAR) for assessment of disease severity in ventilator-associated pneumonia and sepsis","volume":"63","author":"Savva","year":"2011","journal-title":"J Infect"},{"key":"10.1016\/j.ijantimicag.2015.10.010_bib0290","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3389\/fmicb.2014.00627","article-title":"Triggering receptor expressed on myeloid cells-1 (TREM-1): a new player in antiviral immunity?","volume":"5","author":"Roe","year":"2014","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2015.10.010_bib0295","doi-asserted-by":"crossref","first-page":"4716","DOI":"10.4238\/2015.May.11.4","article-title":"Values for serum procalcitonin, C-reactive protein, and soluble triggering receptor expressed on myeloid cells-1 in predicting survival of patients with early-onset stroke-associated pneumonia","volume":"14","author":"Xie","year":"2015","journal-title":"Genet Mol Res"},{"key":"10.1016\/j.ijantimicag.2015.10.010_bib0300","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/EJA.0b013e328329afca","article-title":"Soluble TREM-1 is not suitable for distinguishing between systemic inflammatory response syndrome and sepsis survivors and nonsurvivors in the early stage of acute inflammation","volume":"26","author":"Bopp","year":"2009","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.ijantimicag.2015.10.010_bib0305","doi-asserted-by":"crossref","first-page":"507","DOI":"10.4161\/viru.24530","article-title":"Biomarkers of endothelial activation\/dysfunction in infectious diseases","volume":"4","author":"Page","year":"2013","journal-title":"Virulence"},{"key":"10.1016\/j.ijantimicag.2015.10.010_bib0310","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/SHK.0b013e31821e4e04","article-title":"Endothelial cell activation in emergency department patients with sepsis-related and non-sepsis-related hypotension","volume":"36","author":"Schuetz","year":"2011","journal-title":"Shock"},{"key":"10.1016\/j.ijantimicag.2015.10.010_bib0315","first-page":"305","article-title":"Does serum lactate combined with soluble endothelial selectins at ICU admission predict sepsis development?","volume":"29","author":"Vassiliou","year":"2015","journal-title":"In Vivo"},{"key":"10.1016\/j.ijantimicag.2015.10.010_bib0320","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1182\/blood-2004-09-3531","article-title":"Angiopoietins can directly activate endothelial cells and neutrophils to promote proinflammatory responses","volume":"105","author":"Lemieux","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ijantimicag.2015.10.010_bib0325","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/CCM.0b013e318206d285","article-title":"Angiopoietin-1 and angiopoietin-2 as clinically informative prognostic biomarkers of morbidity and mortality in severe sepsis","volume":"39","author":"Ricciuto","year":"2011","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2015.10.010_bib0330","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.cyto.2008.09.003","article-title":"Kinetics of angiopoietin-2 in serum of multi-trauma patients: correlation with patient severity","volume":"44","author":"Giamarellos-Bourboulis","year":"2008","journal-title":"Cytokine"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857915003593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857915003593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T22:26:04Z","timestamp":1599776764000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857915003593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":33,"alternative-id":["S0924857915003593"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2015.10.010","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarkers in infection and sepsis: Can they really indicate final outcome?","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2015.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}